CLSI H56 A : 1ED 2006

Abstract
Committee Membership
Foreword
1 Scope
2 Standard Precautions
3 Definitions
4 Preanalytical Variables
5 Specimen Collection
   5.1 Cerebrospinal Fluid
   5.2 Serous Fluid
   5.3 Synovial Fluid
   5.4 Bronchoalveolar Lavage (BAL)
6 Specimen Handling and Transport
   6.1 CSF
   6.2 Serous Fluids
   6.3 Synovial Fluids
   6.4 BAL
7 Quantitative Assessment
   7.1 Manual Counting
   7.2 Automated Methods
8 Morphology Assessment
   8.1 Slide Preparation
   8.2 Identification of Morphologic Constituents
   8.3 Evaluation of Nucleated Cell Subtypes
   8.4 Physician Review
   8.5 Result Reporting
9 Fluid Types
   9.1 Cerebrospinal Fluid and Ventricular Shunt Fluids
   9.2 Serous (Pleural, Peritoneal, Pericardial,
        Peritoneal Lavage and Dialysate Fluids)
   9.3 Synovial Fluid
   9.4 Bronchoalveolar Lavage Fluid
10 Additional Studies
   10.1 Immunocytologic Studies
   10.2 Flow Cytometric Studies
   10.3 Cytogenetic Analysis
11 Sample Storage After Completion of Testing
12 Quality Control and Quality Assurance
   12.1 Quality Control
   12.2 Quality Assurance
   12.3 Proficiency Testing (External Quality Assessment)
   12.4 Continuous Education and Training
References
Additional References
Appendix A - Reagent Formulations
Appendix B - Interpretation of Cell Types
Appendix C - Reference Intervals
Summary of Comments and Subcommittee Responses
The Quality System Approach
Related CLSI/NCCLS Publications